ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Management of premature ejaculation
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 191360" data-attributes="member: 13851"><p><strong>Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine <span style="color: rgb(184, 49, 47)">(SIAMS)</span></strong></p><p><span style="color: rgb(44, 130, 201)">A. Sansone · A. Aversa · G. Corona · A. D. Fisher · A. M. Isidori · S. La Vignera · E. Limoncin · M. Maggi · M. Merico · E. A. Jannini </span></p><p></p><p></p><p><strong>Abstract</strong></p><p></p><p><span style="color: rgb(184, 49, 47)"><em>Premature ejaculation (PE) is the most prevalent male sexual dysfunction, and the most recently defined. </em></span><em><span style="color: rgb(44, 130, 201)">PE is often mistakenly considered a purely psychosexological symptom by patients: the lacking awareness in regards to the pathophysiology and treatments often leads to resignation from the patients’ side, making PE the most underdiagnosed sexual complaint.</span></em> <span style="color: rgb(184, 49, 47)"><em><u>However, an ever-growing body of evidence supporting several organic factors has been developed in the last decades and several definitions have been suggested to encompass all defining features of PE</u>.</em></span> <span style="color: rgb(44, 130, 201)"><em>In the present document by the Italian Society of Andrology and Sexual Medicine (SIAMS), we propose 33 recommendations concerning the definition, pathophysiology, treatment, and management of PE aimed to improve patient care.</em></span> <span style="color: rgb(184, 49, 47)"><em><u>These evidence-based clinical guidelines provide the necessary up-to-date guidance in the context of PE secondary to organic and psychosexological conditions, such as prostate inflammation, endocrine disorders, and other sexual dysfunctions, and suggest how to associate pharmacotherapies and cognitive-behavioral therapy in a couple-centered approach</u>. New therapeutic options, as well as combination and off-label treatments, are also described</em></span></p><p></p><p></p><p></p><p></p><p></p><p><strong>Introduction </strong></p><p></p><p><span style="color: rgb(184, 49, 47)"><em>The inclusion of premature ejaculation (PE) in the radar of science and medicine is relatively recent and still debated:</em></span><span style="color: rgb(44, 130, 201)"> <em>the perception that PE is a psychological or, at the best, sexological symptom, almost exclusively due to behavioral relational derangements is indeed well-rooted [1–3].</em></span><span style="color: rgb(184, 49, 47)"><em> Patients and media are only partially aware of the solid body of evidence produced in the context of diagnosis, pathogenesis, and treatment of PE. </em></span></p><p><span style="color: rgb(184, 49, 47)"><em></em></span></p><p><span style="color: rgb(184, 49, 47)"><em>Being one of the “youngest” topics for sexual medicine, many aspects of PE still need to be clarified on the basis of adequate evidence. </em></span><span style="color: rgb(44, 130, 201)"><em>The aim of this clinical guideline is to examine the current findings able to impact on the clinical management of the patient and the couple with PE.</em></span></p><p></p><p></p><p></p><p></p><p></p><p><strong>Definitions of premature ejaculation</strong></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p></p><p><strong>Pathophysiology of premature ejaculation</strong></p><p><span style="color: rgb(184, 49, 47)">Genetics </span></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p><span style="color: rgb(184, 49, 47)">Remarks</span></p><p></p><p><strong>Hyperthyroidism </strong></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p><span style="color: rgb(184, 49, 47)">Remarks</span></p><p></p><p><strong>Prostatitis/chronic pelvic pain syndrome </strong></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p><span style="color: rgb(184, 49, 47)">Remarks</span></p><p></p><p><span style="color: rgb(0, 0, 0)"><strong>Other factors </strong></span></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p><span style="color: rgb(184, 49, 47)">Remarks</span></p><p></p><p><span style="color: rgb(0, 0, 0)"><strong>Other sexual comorbidities </strong></span></p><p><span style="color: rgb(184, 49, 47)">Erectile dysfunction </span></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p><span style="color: rgb(184, 49, 47)">Remarks</span></p><p></p><p><strong>Infertility </strong></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p><span style="color: rgb(184, 49, 47)">Remarks</span></p><p></p><p><strong>Diagnosis </strong></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p><span style="color: rgb(184, 49, 47)">Remarks</span></p><p></p><p><strong>Psychometry, psychology, psychotherapy </strong></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p><span style="color: rgb(184, 49, 47)">Remarks</span></p><p></p><p><strong>On‑label therapies </strong></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p><span style="color: rgb(184, 49, 47)">Remarks</span></p><p></p><p><strong>Off‑label therapies </strong></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p><span style="color: rgb(184, 49, 47)">Remarks</span></p><p></p><p><strong>Surgical treatment </strong></p><p><span style="color: rgb(184, 49, 47)">Evidence</span></p><p></p><p></p><p></p><p></p><p><strong>Conclusion </strong></p><p></p><p><span style="color: rgb(184, 49, 47)"><em><strong><u>PE is a frequent and multifaceted symptom, which has only recently been considered of interest to the physician</u>. As a consequence, only a few drugs have been developed and approved yet for PE, and in many countries, no treatment has been approved so far.</strong></em></span><span style="color: rgb(44, 130, 201)"><strong><em> <u>Hence, management of PE remains relatively complex and might become a source of dissatisfaction for both patients and clinicians</u>.</em></strong></span> <span style="color: rgb(184, 49, 47)"><em><strong>While DE is destroying the quantitative aspect of sexuality, being the intercourse impossible in the majority of impotent men, PE is affecting the quality of sex itself. <u>Many patients are apparently refractory to simple pharmacological treatment or psychological therapy alone</u>.</strong></em></span><span style="color: rgb(44, 130, 201)"><em><strong><u> Hence, its management and the patient and partner expectations appear more difficult, possibly explaining the disappointment encountered by many doctors with a simplistic approach to PE</u>.</strong></em></span><span style="color: rgb(184, 49, 47)"><em><strong> <u>While PE should always be thoroughly investigated by a specialist, all physicians can (and should) ask their patients whether any sexual dysfunction is present in their life: a flowchart summarizing most of the present guidelines’ recommendations could be helpful to guide all necessary steps in diagnosis and treatment (Figs. 1 and 2</u>). </strong></em></span><span style="color: rgb(44, 130, 201)"><em><strong>Our clinical guideline has been therefore developed to introduce new elements that are likely to have critical repercussions for the daily clinical practice and for the successful treatment of PE. </strong></em></span></p></blockquote><p></p>
[QUOTE="madman, post: 191360, member: 13851"] [B]Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine [COLOR=rgb(184, 49, 47)](SIAMS)[/COLOR][/B] [COLOR=rgb(44, 130, 201)]A. Sansone · A. Aversa · G. Corona · A. D. Fisher · A. M. Isidori · S. La Vignera · E. Limoncin · M. Maggi · M. Merico · E. A. Jannini [/COLOR] [B]Abstract[/B] [COLOR=rgb(184, 49, 47)][I]Premature ejaculation (PE) is the most prevalent male sexual dysfunction, and the most recently defined. [/I][/COLOR][I][COLOR=rgb(44, 130, 201)]PE is often mistakenly considered a purely psychosexological symptom by patients: the lacking awareness in regards to the pathophysiology and treatments often leads to resignation from the patients’ side, making PE the most underdiagnosed sexual complaint.[/COLOR][/I] [COLOR=rgb(184, 49, 47)][I][U]However, an ever-growing body of evidence supporting several organic factors has been developed in the last decades and several definitions have been suggested to encompass all defining features of PE[/U].[/I][/COLOR] [COLOR=rgb(44, 130, 201)][I]In the present document by the Italian Society of Andrology and Sexual Medicine (SIAMS), we propose 33 recommendations concerning the definition, pathophysiology, treatment, and management of PE aimed to improve patient care.[/I][/COLOR] [COLOR=rgb(184, 49, 47)][I][U]These evidence-based clinical guidelines provide the necessary up-to-date guidance in the context of PE secondary to organic and psychosexological conditions, such as prostate inflammation, endocrine disorders, and other sexual dysfunctions, and suggest how to associate pharmacotherapies and cognitive-behavioral therapy in a couple-centered approach[/U]. New therapeutic options, as well as combination and off-label treatments, are also described[/I][/COLOR] [B]Introduction [/B] [COLOR=rgb(184, 49, 47)][I]The inclusion of premature ejaculation (PE) in the radar of science and medicine is relatively recent and still debated:[/I][/COLOR][COLOR=rgb(44, 130, 201)] [I]the perception that PE is a psychological or, at the best, sexological symptom, almost exclusively due to behavioral relational derangements is indeed well-rooted [1–3].[/I][/COLOR][COLOR=rgb(184, 49, 47)][I] Patients and media are only partially aware of the solid body of evidence produced in the context of diagnosis, pathogenesis, and treatment of PE. Being one of the “youngest” topics for sexual medicine, many aspects of PE still need to be clarified on the basis of adequate evidence. [/I][/COLOR][COLOR=rgb(44, 130, 201)][I]The aim of this clinical guideline is to examine the current findings able to impact on the clinical management of the patient and the couple with PE.[/I][/COLOR] [B]Definitions of premature ejaculation[/B] [COLOR=rgb(184, 49, 47)]Evidence[/COLOR] [B]Pathophysiology of premature ejaculation[/B] [COLOR=rgb(184, 49, 47)]Genetics Evidence Remarks[/COLOR] [B]Hyperthyroidism [/B] [COLOR=rgb(184, 49, 47)]Evidence Remarks[/COLOR] [B]Prostatitis/chronic pelvic pain syndrome [/B] [COLOR=rgb(184, 49, 47)]Evidence Remarks[/COLOR] [COLOR=rgb(0, 0, 0)][B]Other factors [/B][/COLOR] [COLOR=rgb(184, 49, 47)]Evidence Remarks[/COLOR] [COLOR=rgb(0, 0, 0)][B]Other sexual comorbidities [/B][/COLOR] [COLOR=rgb(184, 49, 47)]Erectile dysfunction Evidence Remarks[/COLOR] [B]Infertility [/B] [COLOR=rgb(184, 49, 47)]Evidence Remarks[/COLOR] [B]Diagnosis [/B] [COLOR=rgb(184, 49, 47)]Evidence Remarks[/COLOR] [B]Psychometry, psychology, psychotherapy [/B] [COLOR=rgb(184, 49, 47)]Evidence Remarks[/COLOR] [B]On‑label therapies [/B] [COLOR=rgb(184, 49, 47)]Evidence Remarks[/COLOR] [B]Off‑label therapies [/B] [COLOR=rgb(184, 49, 47)]Evidence Remarks[/COLOR] [B]Surgical treatment [/B] [COLOR=rgb(184, 49, 47)]Evidence[/COLOR] [B]Conclusion [/B] [COLOR=rgb(184, 49, 47)][I][B][U]PE is a frequent and multifaceted symptom, which has only recently been considered of interest to the physician[/U]. As a consequence, only a few drugs have been developed and approved yet for PE, and in many countries, no treatment has been approved so far.[/B][/I][/COLOR][COLOR=rgb(44, 130, 201)][B][I] [U]Hence, management of PE remains relatively complex and might become a source of dissatisfaction for both patients and clinicians[/U].[/I][/B][/COLOR] [COLOR=rgb(184, 49, 47)][I][B]While DE is destroying the quantitative aspect of sexuality, being the intercourse impossible in the majority of impotent men, PE is affecting the quality of sex itself. [U]Many patients are apparently refractory to simple pharmacological treatment or psychological therapy alone[/U].[/B][/I][/COLOR][COLOR=rgb(44, 130, 201)][I][B][U] Hence, its management and the patient and partner expectations appear more difficult, possibly explaining the disappointment encountered by many doctors with a simplistic approach to PE[/U].[/B][/I][/COLOR][COLOR=rgb(184, 49, 47)][I][B] [U]While PE should always be thoroughly investigated by a specialist, all physicians can (and should) ask their patients whether any sexual dysfunction is present in their life: a flowchart summarizing most of the present guidelines’ recommendations could be helpful to guide all necessary steps in diagnosis and treatment (Figs. 1 and 2[/U]). [/B][/I][/COLOR][COLOR=rgb(44, 130, 201)][I][B]Our clinical guideline has been therefore developed to introduce new elements that are likely to have critical repercussions for the daily clinical practice and for the successful treatment of PE. [/B][/I][/COLOR] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Management of premature ejaculation
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top